Study title: Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease. Landgren O, Axdorph U, Jacobsson H, Johansson B, Grimfors G, Björkholm M. Med Oncol. 2000 Aug;17(3):174-8.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Diagnosis [E01] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID | |||||
ATC code: V09BA02 | |||||
Document link: | |||||
Document date: 2014-12-04 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |